Karin de Haart

Karin de Haart has gained more than 15 years of experience working in drug development and clinical research after receiving her MSc in Health Sciences. Karin joined IQVIA Real World Evidence Solutions in 2009, leading both prospective and retrospective noninterventional studies, including rare disease and pregnancy registries. She has experience in a range of therapeutic areas. In her current role as Product Strategy Lead, she supports marketing global Real World Evidence Solutions study teams with assessing and implementing innovative approaches and study designs to generate safety evidence for regulators.